US EditionNovo Nordisk Lowering Prices for Weight Loss, Diabetes Drugs for Cash Customers
Novo Nordisk reduces Wegovy and Ozempic prices, starting at $199 monthly, to boost access and compete with rivals. One in eight adults use GLP-1 drugs, a KFF poll found.
6 Articles
6 Articles
Novo Nordisk lowering prices for weight loss, diabetes drugs for cash customers
Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy 0.25 mg and 0.5 mg injections and Ozempic will be $199 a month for new self-pay patients until March 31, 2026, Novo Nordisk…
Novo Nordisk to offer some doses of Ozempic, Wegovy for $199 for a limited time
GLP-1 weight loss drugs are still far from cheap, but some of the prices keep dropping. Novo Nordisk is now offering people who pay out of pocket a steep discount for select doses of Ozempic and Wegovy, the company said Monday. Until the end of March, Novo Nordisk will let people with a…
Wegovy, Ozempic prices to be cut for consumers
NEW YORK (PIX11) — Good news for consumers battling the high cost of weight loss drugs. Novo Nordisk, the maker of Wegovy and Ozempic, announced it will cut prices. For cash-paying patients, the price drops from $499 a month to $349 a month. The highest dose of Ozempic remains $499 per month. New cash-paying patients [...]
Novo starts price agreement early: Lowers US prices immediatelyAlthough Novo Nordisk will not lower the prices of Wegovy and Ozempic in the US until next year, the Danish pharmaceutical giant is already starting on Monday with
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
